any news?, page-2

with nearly half of their on balance sheet debt being reduced by aug 09 approx 200 mill as forecasted by the company and 80 billion [us] of drugs coming off patent over the next two years you really have to wonder..........sip ebitda up 28.7 and ebit up27.6 on first half so minus the debt and add some big selling off-patents and what do you get?..... these are my personal opinions only and should not be used as grounds to buy or sell stock in sigma ...